Scott Shevick has covered the ethical and generic pharmaceutical
industries for over 16 years and has written extensively on trends in
the pharmaceutical industry, as well as companies. He and his partner,
Joe Riccardo, have been ranked by Institutional Investor for over a
decade. Prior to joining Bear, Stearns in 1992, Mr. Shevick was the
senior pharmaceutical analyst at Rothschild Inc. From 1986 to 1992, Mr.
Shevick was the senior pharmaceutical and healthcare analyst and
portfolio manager for Mercantile Safe Deposit and Trust. He is a
Chartered Financial Analyst (CFA) and a member of the New York Society
of Security Analysts. Mr Shevick earner an MS in Finance from the
University of Baltimore and a BS from the E. Claiborne Robins School of
Business at the University of Richmond.
U.s. Pharmaceutical Companies: J.riccardo/s.shevick - Bear, Stearns & Co
September 13, 2002